Research Papers:

This article has been corrected. Correction in: Oncotarget. 2018; 9:27585.

6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ

Qinghe Han _, Qinghai Yuan and Guanghong Xie

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:42001-42006. https://doi.org/10.18632/oncotarget.16719

Metrics: PDF 4474 views  |   HTML 4564 views  |   ?  


Qinghe Han2, Qinghai Yuan2 and Guanghong Xie1

1College of Veterinary Medicine, Jilin University, Changchun 130062, China

2The Second Hospital of Jilin University, Changchun 130000, China

Correspondence to:

Guanghong Xie, email: [email protected]

Keywords: 6-Shogaol, LPS, PPAR-γ, BV2 microglia

Received: November 08, 2016     Accepted: March 01, 2017     Published: March 30, 2017


6-Shogaol, a pungent agent isolated from Zingiber officinale Roscoe, has been known to have anti-tumor and anti-inflammatory effects. However, the anti-inflammatory effects and biological mechanism of 6-Shogaol in LPS-activated BV2 microglia remains largely unknown. In this study, we evaluated the anti-inflammatory effects of 6-Shogaol in LPS-activated BV2 microglia. 6-Shogaol was administrated 1 h before LPS treatment. The production of inflammatory mediators were detected by ELISA. The expression of NF-κB and PPAR-γ were detected by western blot analysis. Our results revealed that 6-Shogaol inhibited LPS-induced TNF-α, IL-1β, IL-6, and PGE2 production in a concentration dependent manner. Furthermore, 6-Shogaol inhibited LPS-induced NF-κB activation by inhibiting phosphorylation and nuclear translocation of NF-κB p65. In addition, 6-Shogaol could increase the expression of PPAR-γ. Moreover, inhibition of PPAR-γ by GW9662 could prevent the inhibition of 6-Shogaol on LPS-induced inflammatory mediator production. In conclusion, 6-Shogaol inhibits LPS-induced inflammation by activating PPAR-γ.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16719